# Fluoxetine for Refractory Constipation

> **NCT06750445** · NA · COMPLETED · sponsor: **Zhifeng Zhao, PhD** · enrollment: 316 (actual)

## Conditions studied

- Refractory Constipation

## Interventions

- **DRUG:** Fluoxetine
- **DRUG:** Polyethylene Glycol 400 0.4%

## Key facts

- **NCT ID:** NCT06750445
- **Lead sponsor:** Zhifeng Zhao, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 316 (ACTUAL)
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06750445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06750445, "Fluoxetine for Refractory Constipation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06750445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*